Galapagos Begins Phase I Study For Novel Cystic Fibrosis Therapy
Cystic Fibrosis, News
Developmental stage Galapagos NV is initiating its first phase 1 study to evaluate a CFTR targeted therapy for the treatment of cystic fibrosis (CF) called GLPG1837. The company is assessing a novel ... Read more